Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/8959
Título
T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response
Autor(es)
Aragoneses-Fenoll, Laura ISCIII | Ojeda, Gloria ISCIII | Montes-Casado, Maria ISCIII | Acosta-Ampudia, Yeny | Dianzani, Umberto | Portoles, Pilar ISCIII | Rojo, José M
Fecha de publicación
2018
Cita
Front Immunol. 2018 Feb 27;9:332.
Idioma
Inglés
Tipo de documento
journal article
Resumen
Class IA phosphatidylinositol 3-kinase (PI3K) catalytic subunits p110α and p110δ are targets in cancer therapy expressed at high levels in T lymphocytes. The role of p110δ PI3K in normal or pathological immune responses is well established, yet the importance of p110α subunits in T cell-dependent immune responses is not clear. To address this problem, mice with p110α conditionally deleted in CD4+ and CD8+ T lymphocytes (p110α-/-ΔT) were used. p110α-/-ΔT mice show normal development of T cell subsets, but slightly reduced numbers of CD4+ T cells in the spleen. "In vitro," TCR/CD3 plus CD28 activation of naive CD4+ and CD8+ p110α-/-ΔT T cells showed enhanced effector function, particularly IFN-γ secretion, T-bet induction, and Akt, Erk, or P38 activation. Tfh derived from p110α-/-ΔT cells also have enhanced responses when compared to normal mice, and IL-2 expanded p110α-/-ΔT CD8+ T cells had enhanced levels of LAMP-1 and Granzyme B. By contrast, the expansion of p110α-/-ΔT iTreg cells was diminished. Also, p110α-/-ΔT mice had enhanced anti-keyhole limpet hemocyanin (KLH) IFN-γ, or IL-4 responses and IgG1 and IgG2b anti-KLH antibodies, using CFA or Alum as adjuvant, respectively. When compared to WT mice, p110α-/-ΔT mice inoculated with B16.F10 melanoma showed delayed tumor progression. The percentage of CD8+ T lymphocytes was higher and the percentage of Treg cells lower in the spleen of tumor-bearing p110α-/-ΔT mice. Also, IFN-γ production in tumor antigen-activated spleen cells was enhanced. Thus, PI3K p110α plays a significant role in antigen activation and differentiation of CD4+ and CD8+ T lymphocytes modulating antitumor immunity.
Palabras clave
MESH
Animals | CD8-Positive T-Lymphocytes | Class I Phosphatidylinositol 3-Kinases | Extracellular Signal-Regulated MAP Kinases | Interferon-gamma | MAP Kinase Signaling System | Mice | Mice, Knockout | Neoplasms, Experimental | Proto-Oncogene Proteins c-akt | T-Lymphocytes, Regulatory | Immunity, Cellular
Versión en línea
DOI
Aparece en las colecciones